Long Bridge Medical, Inc. — SEC Form D Filing
Long Bridge Medical, Inc. filed an SEC Form D on August 13, 2026, reporting $2.54M raised in Medical Devices.
Form D filing details
- Filing
- SEC Form D
- Filing date
- August 13, 2026
- Amount reported
- $2.54M
- Industry
- Medical Devices
- Website
- https://longbridgemedical.com/
What the company does
Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
Patients with inadequate capsular support in their eyes, who are also poor candidates for an Anterior Chamber IOL (ACIOL), lack a standardized way to achieve stable and centered positioning of intraocular lenses.
Solution
Long Bridge Medical is developing the LensOne™ platform, a prosthetic capsular bag designed to restore capsular support and provide stable, centered positioning for intraocular lenses.
Verdict
Investors backed this company on the promise of a novel medical device addressing a complex surgical challenge in ophthalmology, implicitly betting on the team's ability to navigate clinical trials and regulatory hurdles with a physically differentiated product. This cleared because the reported problem's severity and lack of alternatives justified development risk, not because the market's commercialization path was well-defined or easily accessible. The upside was limited by the long development cycles and the immediate need for a robust clinical validation that would satisfy conservative medical device adoption cycles.
Source: SEC EDGAR Form D filing